Yuquan Pei

621 total citations
11 papers, 116 citations indexed

About

Yuquan Pei is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yuquan Pei has authored 11 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yuquan Pei's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yuquan Pei is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yuquan Pei collaborates with scholars based in China, Ethiopia and United States. Yuquan Pei's co-authors include Shaolei Li, Yue Yang, Qingfeng Zheng, Yuzhao Wang, Chao Lv, Wentao Fang, Shanyuan Zhang, Jia Wang, Yue Yang and Shidong Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Lung Cancer.

In The Last Decade

Yuquan Pei

10 papers receiving 116 citations

Peers

Countries citing papers authored by Yuquan Pei

Since Specialization

Citations

This map shows the geographic impact of Yuquan Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuquan Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuquan Pei more than expected).

Fields of papers citing papers by Yuquan Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuquan Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuquan Pei. The network helps show where Yuquan Pei may publish in the future.

Co-authorship network of co-authors of Yuquan Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Yuquan Pei. A scholar is included among the top collaborators of Yuquan Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuquan Pei. Yuquan Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Constructing nursing quality indicators for intraoperative acquired pressure injury in cancer patients based on guidelines 2024 ·International Journal for Quality in Health Care ·Yu Zhou, (unknown), (unknown), (unknown), Yuquan Pei, (unknown)	0
2	Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial 2023 ·Lung Cancer ·Chao Lv, Wentao Fang, Nan Wu, Wenjie Jiao, Shidong Xu, (unknown), Jia Wang, Rui Wang, Chunyu Ji, Shaolei Li, Yuzhao Wang, Yan Shi, (unknown), Yuquan Pei, Yinan Liu, Yue Yang	47
3	Intermittent chest tube clamping decreases chest tube duration time and drainage volume after lung cancer surgery in patients without air leak: an open-label, randomized controlled trial 2022 ·Translational Lung Cancer Research ·Yaqi Wang, Yuquan Pei, Chao Lv, Yuzhao Wang, Jia Wang, (unknown), Xiang Li, Yue Yang, Anthony W. Kim, Alper Toker, Yan Shi, Nan Wu	1
4	Different exposure duration of adjuvant icotinib in stage II-IIIA non-small cell lung cancer patients with positive EGFR mutation (ICOMPARE study): A randomized, open-label phase 2 study. 2021 ·Journal of Clinical Oncology ·Chao Lyu, Rui Wang, Shaolei Li, Yan Shi, Yuzhao Wang, Jinfeng Chen, Liang Wang, Yinan Liu, (unknown), Jia Wang, Yuquan Pei, Lei Yu, Nan Wu, Jun Chen, (unknown), Shanqing Li, (unknown), Lieming Ding, Li Mao, Yue Yang	8
5	Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles 2019 ·Journal of Computational Biology ·(unknown), Yuquan Pei, Shaolei Li, Shanyuan Zhang, Yue Yang	7
6	[Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer]. 2019 ·SHILAP Revista de lepidopterología ·Shanyuan Zhang, Liang Wang, (unknown), Yuquan Pei, Yue Yang	2
7	Left sleeve lobectomy versus left pneumonectomy for the management of patients with non‐small cell lung cancer 2018 ·Thoracic Cancer ·(unknown), Yuquan Pei, Shaolei Li, (unknown), Yue Yang	3
8	Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non‐small cell lung cancer 2017 ·Thoracic Cancer ·Dan Tian, Yuquan Pei, Qingfeng Zheng, Jianzhi Zhang, Shaolei Li, Xing Wang, Dongmei Lin, Yue Yang	18
9	Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates 2017 ·Journal of Thoracic Disease ·Shanyuan Zhang, Shaolei Li, Yuquan Pei, Miao Huang, (unknown), Qingfeng Zheng, Nan Li, Yue Yang	6
10	Retrospective study of surgical resection in the treatment of limited stage small cell lung cancer 2013 ·Thoracic Cancer ·Qingfeng Zheng, Shaolei Li, Lijian Zhang, Nan Wu, Jinfeng Chen, Yuzhao Wang, Yan Shi, Bingtian Zhao, Yuanshan Yao, Yuquan Pei, Yuanyuan Ma, Yue Yang	7
11	A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma 2013 ·World Journal of Surgical Oncology ·Chao Lv, Yuanyuan Ma, Qin Feng, Fang Fang, Hua Bai, Bingtian Zhao, Yan Shi, Nan Wu, Qingfeng Zheng, Shaolei Li, Jinfeng Chen, Jia Wang, (unknown), Yuzhao Wang, Yuquan Pei, Jian Fang, Yue Yang	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact